Iterum Therapeutics raises $40 mln

Iterum Therapeutics Ltd said Thursday it raised $40 million in a Series A round led by Frazier Healthcare Partners and joined by Canaan Partners, Sofinnova Ventures and New Leaf Venture Partners. Iterum, of Dublin, is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives.

North AmericaUSBriefs